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Abstract: B12 is unique among the vitamins as it is biosynthe-
sized only by certain prokaryotes. The complexity of its
synthesis relates to its distinctive cobalt corrin structure, which
is essential for B12 biochemistry and renders coenzyme B12
(AdoCbl) so intriguingly suitable for enzymatic radical
reactions. However, why is cobalt so fit for its role in B12-
dependent enzymes? To address this question, we considered
the substitution of cobalt in AdoCbl with rhodium to generate
the rhodium analogue 5’-deoxy-5’-adenosylrhodibalamin
(AdoRbl). AdoRbl was prepared by de novo total synthesis
involving both biological and chemical steps. AdoRbl was
found to be inactive in vivo in microbial bioassays for
methionine synthase and acted as an in vitro inhibitor of an
AdoCbl-dependent diol dehydratase. Solution NMR studies of
AdoRbl revealed a structure similar to that of AdoCbl.
However, the crystal structure of AdoRbl revealed a conspic-
uously better fit of the corrin ligand for RhIII than for CoIII,
challenging the current views concerning the evolution of
corrins.
The biochemical activity of the biological forms of B12 is
based on the pivotal role played by the cobalt center bound by
the corrin ring.[1] However, why is cobalt, rather than any
other metal, so suited to its role in B12?
[1b] This old question
has posed a formidable challenge.[1, 2] Interestingly, cobalt was
given its name because German miners found it in ores
contaminated with arsenic, and believed it was added
malevolently by “Kobolds”, or goblins. To address the
“cobalt question”, we considered the replacement of cobalt
by its heavier Group IX homologue rhodium. The specific
suitability of coenzyme B12 (5’-deoxy-5’-adenosylcobalamin,
AdoCbl; Figure 1) as a catalytic radical source by enzyme-
controlled homolytic cleavage of its Co¢C bond[3] suggested
that its rhodium homologue, 5’-deoxy-5’-adenosyl-rhodibala-
min (AdoRbl), would be a particularly interesting target.
AdoRbl was first prepared in the 1970s via metal-free
hydrogenobalamin, which was isolated in low yields from
cultures of Chromatium vinosum grown in cobalt-free media,
but incompletely characterized.[2a] Unfortunately, various
alternative strategies to generate metal analogues of the
natural corrinoids by removal of the Co center of vitamin B12
Figure 1. Chemical formula of coenzyme B12 (M=Co
III, AdoCbl) and
5’-deoxy-5’-adenosylrhodibalamin (M=RhIII, AdoRbl).
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derivatives have not been successful (see e.g. Ref. [4]);
therefore, a novel approach for its preparation was required.
Herein, we describe a concise total synthesis of AdoRbl
through a strategical combination of biological and chemical
means, and report its structural and basic biological proper-
ties. Indeed, as described below, by asking “Why not
rhodium?”, we have addressed a related fundamental ques-
tion concerning the evolutionary selection and adaptation of
corrins.
Complementary chemical and biological methods were
developed for the synthesis of 5’-deoxy-5’adenosylrhodibala-
min (AdoRbl; Figure 2). Initially, hydrogenobyrinic acid a,c-
diamide (Hbad) was synthesized de novo and in vivo using an
engineered E. coli strain containing the ten genes (cobA-I-G-
J-M-F-K-L-H-B) that encode the enzymes for the biosynthe-
sis of cobalamin from the endogenous biosynthetic inter-
mediate uroporphyrinogen III.[5] From around 30 L of cul-
ture, 88.2 mg of Hbad were obtained. Hbad was converted
into rhodibyrinic acid a,c-diamide by chemical insertion of
RhI.[6] Orange-red dicyanorhodi(III)byrinic acid a,c-diamide
(CN2-Rhbad)
[6b]was obtained in 75% yield, but unfortunately
proved to be resistant to refunctionalization into
adenosylrhodi(III)byrinic acid a,c-diamide (AdoRhbad).
However, AdoRhbad was synthetically accessible when
rhodibyrinic acid a,c-diamide was isolated as the dichloro-
substituted RhIII corrinoid (DCRhbad), which was character-
ized by UV/Vis spectroscopy and mass spectrometry. Reduc-
tion of DCRhbad with sodium borohydride in deoxygenated
solution led to the light yellowRhI corrinoid. Treatment of the
latter with 5’-iodo-5’-deoxyadenosine (0 8C!RT) gave an
orange reaction mixture from which AdoRhbad could be
isolated in 75% yield. The molecular formula of AdoRhbad
was confirmed by ESI mass spectrometry (m/z 1230.3 [M]+).
Its UV/Vis spectrum was similar to those of the dichloro and
dicyano RhIII analogues (see the Supporting Information,
Figure S1). The metal-bound methylene group of the
5’-deoxyadenosyl moiety of AdoRhbad gave rise to two
characteristic multiplets at high field in the 1H NMR
spectrum, which were assigned to the diastereotopic protons
of this CH2 group (Figure S2). Both of these resonances of
AdoRhbad showed a diagnostic 1.7 Hz coupling with 103Rh
(I= 1/2).
With the Rh analogue of
adenosylcobyrinic acid a,c-dia-
mide in hand, the cobalamin
(Cbl) biosynthetic pathway was
again employed, namely in the
form of CobQ,[7] to specifically
amidate four of the remaining
five side-chain carboxyl groups,
thus converting AdoRhbad into
adenosylrhodi(III)byric acid
(AdoRhby; see Figure 2).
Indeed, AdoRhbad served
remarkably well as a pseudo-
substrate for CobQ and fur-
nished AdoRhby in 92% yield.
The regiospecific fourfold ami-
dation of the peripheral side
chains was confirmed by ESI
mass spectrometry and 1H
NMR spectroscopy.
5’-Deoxy-5’-adenosylrhodi-
balamin (AdoRbl), the Rh ana-
logue of coenzyme B12
(AdoCbl), was prepared by
chemical conjugation of AdoR-
hby with the B12 nucleotide
moiety.[1a, 8] This was achieved
by activation of AdoRhby with
the carbodiimide reagent 1-
ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) in the
presence of the B12 nucleotide, furnishing the orange-red
AdoRbl in 79% yield. The UV/Vis spectrum of isolated
AdoRbl showed absorption maxima at l= 512, 491, and
350 nm (Figure S1), as reported previously.[2] The spectrum of
AdoRbl is surprisingly similar to that of cyanocobalamin
(vitamin B12), but differs significantly from that of coenzyme
B12 (AdoCbl). As also noted earlier,
[3] AdoRbl does not
decompose when exposed to daylight in aerated solutions, in
contrast to the photosensitive AdoCbl.[9]
The 500 MHz 1H NMR spectrum of AdoRbl in D2O
contained resonances for all carbon-bound H atoms, includ-
ing the characteristic doublet- and triplet-like signals at high
field for the Rh-bound CH2 group of the Ado ligand
(Figure 3). This latter finding is in striking contrast to the
spectrum reported in the earlier work on AdoRbl, where such
signals were not recorded.[2] The high-field resonances of the
Figure 2. Total synthesis of 5’-deoxy-5’-adenosyl-rhodi(III)balamin (AdoRbl) by intertwined enzymatic
steps of the machinery for the biosynthesis of AdoCbl (bio) and chemical steps (chem) in the sequence
bio-chem-chem-bio-chem. AdoRbl cannot be made from AdoCbl.
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diastereotopic protons HAC5RL and HBC5RL of AdoRbl
correspond to similar resonances in the spectrum of AdoCbl,
identified there as Hre and Hsi, respectively, but both are
shifted upfield by about d= 1.31 ppm. The crystal structure of
AdoRbl exhibits an antiperiplanar arrangement of HC4RL
and of Hre at C5RL, also supporting the assignment of the
triplet-like resonance of HAC5RL to Hre.
1H,1H NOE spectra
(Figures S3 and S4) helped to confirm the base-on nature of
AdoRbl and the attachment of the 5’-deoxyadenosyl moiety
at the b-side of the corrin-bound Rh center. The 2D NMR
data provided further characteristic chemical shift informa-
tion (e.g., for the protons in the side chains of ring B; see
Tables S1–S3), indicating similar conformations of the corrin
ligand and both axially bound groups for AdoRbl and
AdoCbl. The structures of AdoRbl and coenzyme B12
(AdoCbl)[10] in aqueous solution are therefore very similar.
AdoRbl crystallized from a solution of water/acetonitrile
as dark red monoclinic prisms (space group C2, No.5). Awell
resolved X-ray crystal structure was obtained for AdoRbl,
which is the first of any metal analogue of the Cbl series. It
confirmed the NMR-derived chemical constitution of
AdoRbl and showed basic structural features similar to
those of AdoCbl[11] (Figure 4 and Figure S6). As in AdoCbl,
the Ado group of AdoRbl is positioned roughly above ring C
of the corrin ring. However, in AdoRbl, it has been rotated
counterclockwise by about 248 (Figure S7), and is held in
position by an unprecedented hydrogen-bonded dimerization
interface involving theAdomoiety and both of the side chains
of ring B (Figure S9). Thus the Ado group is closer to ring B
in AdoRbl than in AdoCbl,[11] and ring B adopts a conforma-
tion unparalleled in Cbls (see below).
The biological activity of AdoRbl as an AdoCbl analogue
was initially investigated in the form of a bioassay[12] by
monitoring the activity of methionine synthase (MetH), and
subsequently by a direct enzymatic assay with diol (propane-
diol) dehydratase (PduCDE). For MetH, which utilizes a B12
cofactor, we employed a plate-based microbiological
bioassay that uses a Salmonella enterica cbiB metE
reporter strain that is reliant upon exogenous cobalamin
(Cbl) for its MetH when grown on minimal media. The
size of the growth circles observed on these plates is
related logarithmically to the quantity of applied Cbl
(Figure 5).
Addition of AdoRbl alone to the bioassay plates did
not promote any growth. However, when AdoRbl was
applied in close proximity to an equivalent amount of
vitamin B12 (CNCbl), a growth inhibition zone around the
AdoRbl application point was observed. Increasing the
concentration of AdoRbl resulted in greater inhibition
(Figure 5). Unexpectedly, a mixture of CNCbl and
AdoRbl resulted in a larger but more diffuse growth
circle. These observed growth patterns indicate that
1) AdoRbl is not converted into an active cofactor form
for methionine synthase, and that 2) AdoRbl acts as an
inhibitor for Cbl either by preventing the uptake of Cbl
from the medium or by competing for the active site of
methionine synthase. Indeed, the larger growth circles
that were observed when CNCbl was mixed with an
excess of AdoRbl can be explained best by the ability of this
analogue to actively interact with the regulation of Cbl uptake
through a B12 riboswitch.
[13] In E. coli and S. enterica, the btuB
riboswitch acts as a feedback control mechanism, with
AdoCbl as the preferred ligand,[13, 14] to switch off the
production of the outer-membrane B12 transporter. The
increased growth circles on the bioassay plates are consistent
with AdoRbl reducing the level of Cbl uptake.
The effect of AdoRbl on the activity of AdoCbl-depen-
dent enzymes was investigated by studying the Citrobacter
freundii 1,2-propanediol dehydratase (Figures S10–S12). The
kinetic constants for the reaction catalyzed by purified 1,2-
propanediol dehydratase were determined by non-linear
regression. The enzyme was found to be inactive with
AdoRbl as a pseudo-coenzyme. However, in the presence of
AdoCbl, the enzyme was active, with a Km value of 3.0 mm for
AdoCbl and kcat= 358 s
¢1 (based on an a2b2g2 quaternary
structure). Both AdoRbl and vitamin B12 were found to be
Figure 3. 500 MHz 1H NMR spectrum of AdoRbl (0.4 mm in D2O, 10 mm
potassium phosphate, pD 7.4, 298 K, suppressed HDO signal).
Figure 4. Stick model of adenosylrhodibalamin (AdoRbl) from the
crystal structure. C gray, N blue, O red, P orange, Rh blue-green. For
details, see Figures S6–S8.
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competitive inhibitors of the enzyme, with Ki values of 6.9 mm
for AdoRbl and 2.5 mm for vitamin B12. These results confirm
that AdoRbl acts as an inhibitory analogue of AdoCbl and is
unable to catalyze the propanediol dehydratase reaction.
The biological roles of cobalt[15] and the functional forms
of B12
[16] appear to be largely interdependent and remarkably
exclusive. Thus the question of why cobalt, rather than any
other transition metal, is found in B12 has spurred interest in
developing metal analogues of B12.
[6] In this respect, the
Group IX metal rhodium represents a prime substitute. We
thus developed a strategy for the total synthesis of 5’-deoxy-
5’-adenosylrhodibalamin (AdoRbl), which is based on a con-
cise sequence of biological and chemical steps. Structural
studies with AdoRbl in solution (by NMR) and in the crystal
confirmed the expected structural similarity to AdoCbl.
However, the crystal structure of AdoRbl also revealed
some remarkable consequences when CoIII is replaced with
a larger RhIII ion in AdoRbl. As expected, all six bonds to the
metal center of AdoRbl were longer than those in AdoCbl,
which is consistent with the 0.06 è larger covalent radius of
Rh.[17] In fact, the four equatorial bonds were found to be
elongated by 0.082(5) è and the axial bonds by only 0.035-
(5) è compared to those in AdoCbl (Figure 6).
Furthermore, the flatter corrin ligand of AdoRbl displays
a record small fold angle of 5.9(2)8 (13.38 in AdoCbl; see
Figures 7, S8, and S9).[18]Ring B of AdoRbl exhibits a striking
reversed conformational twist when compared to the struc-
tures of AdoCbl and other natural corrinoids. Ring B of
AdoRbl is also flattened, and its acetamide and propionamide
substituents are both in a pseudo-equatorial position. In
contrast, the NMR solution structure indicated a ring B
conformation in AdoRbl matching that in AdoCbl,[10] and
revealed no sign of the unprecedented “reversed” twist. Thus
ring B of AdoRbl is, in fact, flexible and undergoes conforma-
tional inversion in the crystal.
Hence, a comparison of the AdoRbl and AdoCbl
structures reveals that, counterintuitively, the larger RhIII
ion fits better into the corrin ligand than the biologically
relevant CoIII ion. Eschenmoser and Kratky have analyzed
the fundamental structural consequences of a mutual misfit
between small coordinated metal ions (e.g., low-spin NiII) and
the coordination hole of tetrapyrrolic macrocycles.[1a, 19] They
suggested that contraction of the macrocycle leads to non-
planar (“saddle-shaped”) porphyrins and a correlated con-
formational change of the four pyrrolic rings. Similar
conformational effects of the mutual misfit of the size of the
metal ion and the coordination hole have been observed for
a range of porphyrinoid metal complexes[20] and have been
Figure 5. AdoRbl in a microbial bioassay. Application of vitamin B12
(CNCbl) to the plate promotes the growth of a S. enterica cbiB metE
strain (A). AdoRbl on its own does not promote growth (B). Mixing
AdoRbl with B12 results in increased growth circles that are noticeably
less dense than the B12 growth halos (C, E, G). Addition of AdoRbl in
close proximity to the point of application of B12 results in the
appearance of a zone of inhibition that gets more extensive as more
AdoRbl is added (D, F, H).
Figure 6. Comparison of the crystal structures of adenosylrhodibala-
min (AdoRbl) and coenzyme B12 (AdoCbl). Bond lengths (in ç) to Co
III
in AdoCbl and to RhIII in AdoRbl.
Figure 7. Comparison of the crystal structures of adenosylrhodibalamin
(AdoRbl, black lines) and coenzyme B12 (AdoCbl, red lines). Top:
Stereoview of the superimposed structures of AdoRbl and AdoCbl,
highlighting the different folding of the corrin core. Bottom: Super-
position of the corrin cores of AdoRbl and AdoCbl in cylindrical
projections, showing the stronger folding of the corrin ligand of
AdoCbl compared to that of AdoRbl as well as the conformational
inversion of ring B (small letters: side chains; capital letters: rings of
the corrin ligand). See the Supporting Information for details.
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recognized to be an important factor in modifying the
biological activity of metal porphyrinoids.[21]
The crystal structure of AdoRbl indicates that the
coordination hole of the corrin ligand is slightly too large
for the coordination of CoIII ions. In fact, in natural CoIII
corrinoids, a significant corrin fold (13.38 in AdoCbl) is also
apparent, as are notable twists of all four pyrrolic rings[22]
(Figure S8). These twists are most prominent in ring B, where
a consistent conformational twist “in phase” with the non-
planar corrin macrocycle is observed.[1a,22a] In contrast, the
crystallographic studies with AdoRbl suggest a significant
conformational relaxation of the corrin macrocycle when
adapting its structure to the coordination requirements of
RhIII.
Nature has evolved the unique “constitutional ring
contraction” of the corrin ligand[1a, 23] to reduce its hole size
and to accommodate cobalt.[24] However, as discussed here,
the structural data are consistent with an additional con-
formational adaptation of the corrin ligand to meet the
effective size of the coordinated CoIII ions. Hence, the
observed better fit of RhIII over CoIII suggests that the
corrin ligand of cobalamin may not primarily be targeted by
Nature to CoIII. As rhodium is not considered to be an
element that is essential for life on Earth,[15] the interaction of
the corrin ligand with Co, rather than Rh, ions deserves close
attention, including reduced CoII and CoI forms. AdoCbl and
cob(II)alamin feature very similar cobalt corrin structures,[25]
but crystallographic data of a CoI corrin are not yet available
(see, for example, Ref. [16a]). A slight expansion of the
coordination hole of the corrin ligand has been calculated to
assist the reduction of CoIII and CoII corrins.[26] It is thus
tempting to suggest that corrins may display a particular fit
and stabilization for the polarizable CoI ions, the action center
of the enigmatic “supernucleophilic” CoI corrins.[1b,16a,b,27] By
analogy with the idea of enzymes evolving to stabilize
a transition state to lower the activation energy of the
reaction,[28] the proposed ability of stabilizing the CoI state
over CoIII and CoII forms would be a crucial aspect of the
corrin ligand in enzyme reactions with CoI corrin intermedi-
ates,[26,27, 29] which are difficult to generate in a biological
environment.[14, 29] This property would have allowed the
selection of B12 to be fine-tuned for its role as an essential
organometallic catalyst for the prebiotic chemistry of life,[30]
in line with the proposed antiquity of cobalt corrins as ancient
cofactors.[1a]
The molecular recipe for the biosynthesis of coenzyme B12
(AdoCbl) is confined to the genomes of only certain
prokaryotes.[31] By combining it with an engineered E. coli
strain, a concise biological/chemical synthesis pathway to
AdoRbl became available. AdoRbl was characterized as
a structural, but not functional, mimic of the B12 coenzyme
AdoCbl. The coenzyme inactivity of the largely isostructural
Rh analogue of coenzyme B12, in combination with the
inhibitory action of AdoRbl, suggests inefficient Rh¢C bond
homolysis of the enzyme-bound AdoRbl. The determina-
tion[32] of the strength of the Rh¢C bond in AdoRbl will
provide an experimental test for this conclusion.
Having re-addressed the fundamental question of “Why
cobalt?”,[1] perhaps we should now ask: “Why not rhodium or
another metal?” Metal analogues of the cobalamins (metba-
lamins) are believed to be inactive as cofactors, which is
consistent with our studies on AdoRbl. Indeed, some
metbalamins have been shown to inhibit bacterial growth.[6]
Suitably structured metbalamins may thus represent effective
B12 antimetabolites or “antivitamins B12”,
[33] which are of
growing interest in view of recent detailed structural studies
concerning remarkable “novel” biological functions of
Cbls.[34] Our combined biological and chemical synthesis
approach to the “rhodium problem” has opened a new entry
to metbalamins and other metallocorrinoids, an exciting
though poorly explored territory in the multifaceted B12 field.
Experimental Section
See the Supporting Information for materials, instruments, strains
used, construction of plasmids, details of synthetic and enzymatic
procedures, spectroscopy, and X-ray crystallography.
X-ray crystallography: CCDC 1450631 (AdoRbl) contains the
supplementary crystallographic data for this paper. These data are
provided free of charge by The Cambridge Crystallographic Data
Centre.
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